Saturday, March 15, 2025 | 10:25 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

GlaxoSmithKline sees hit from China corruption scandal

GSK's worldwide sales in the quarter were $10.17 billion, generating core earnings per share (EPS) up one per cent at 26.3 pence

Reuters
GlaxoSmithKline , rocked by charges of corruption in China, reported a modest two per cent rise in second-quarter group sales on Wednesday but said the bribery scandal would inevitably have an impact. "Clearly, we are likely to see some impact to our performance in China as a result of the current investigation, but it is too early to quantify the extent of this," Chief Executive Andrew Witty said.

GSK's worldwide sales in the quarter were £6.62 billion ($10.17 billion), generating core earnings per share (EPS) up one per cent at 26.3 pence. Analysts, on average, had forecast sales of £6.60 billion and core EPS, which excludes certain items, of 26.2p, according to Thomson Reuters.
 
The company reiterated that it expected sales growth for the year to be around 1 per cent in local currency terms, with EPS rising by between three and four per cent.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 24 2013 | 11:39 PM IST

Explore News